ESTRO 2024 - Abstract Book
S2219
Clinical - Upper GI
ESTRO 2024
Conclusion:
In this preliminary analysis, adjuvant SBRT in pancreatic cancer proved to be a safe and well tolerated approach without ≥G3 toxicity. We will await the final results to confirm these data.
Keywords: SBRT, Pancreatic cancer, Adjuvant therapy
1981
Digital Poster
Spleen and vertebral body dose associations with lymphopenia after ablative pancreas radiotherapy
Michael D Chuong 1 , Robert Herrera 1 , Nicolas Carvallo 1 , Muni Rubens 1 , Rupesh Kotecha 1 , Matthew D Hall 1 , Kathryn E Mittauer 1 , Nema Bassiri-Gharb 1 , Alonso N Gutierrez 2 , Adeel Kaiser 1
1 Miami Cancer Institute, Radiation Oncology, Miami, USA. 2 Miami Cancer Institue, Radiation Oncology, Miami, USA
Made with FlippingBook - Online Brochure Maker